Docosahexaenoic acid signalolipidomics in nutrition: Significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases

Annual Review of Nutrition

Volumn 31, Issue , 2011, Pages 321-351

  Bazan, Nicolas G ^a   Molina, Miguel F ^a   Gordon, William C ^a  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Liver; Neuroprotectin D1; Omega 3 fatty acids; Phagocytosis; Photoreceptors; Retinal pigment epithelial cells

Indexed keywords

ANTIINFLAMMATORY AGENT; DOCOSAHEXAENOIC ACID; DOCOSANOID; LINOLENIC ACID; NEUROPROTECTIN D1; NEUROTROPHIN; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHOLIPID; UNCLASSIFIED DRUG;

AGING; ALZHEIMER DISEASE; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOGENESIS; CELL COMPARTMENTALIZATION; CELL SURVIVAL; COGNITIVE DEFECT; DEGENERATIVE DISEASE; DRUG SYNTHESIS; ENDOPLASMIC RETICULUM; GENETIC TRANSCRIPTION; HOMEOSTASIS; HUMAN; LIPIDOMICS; LIVER CELL; NERVE REGENERATION; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PHOSPHOLIPID SYNTHESIS; PHOTORECEPTOR INNER SEGMENT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA MACULA DEGENERATION; SIGNAL TRANSDUCTION; SUBRETINAL NEOVASCULARIZATION; SYNAPTOGENESIS; VITAMIN SUPPLEMENTATION;

AGING; ANIMALS; DEFICIENCY DISEASES; DIET; DOCOSAHEXAENOIC ACIDS; FATTY ACIDS, ESSENTIAL; GENE EXPRESSION REGULATION; HUMANS; MACULAR DEGENERATION; METABOLOMICS; NEURITIS; NEURODEGENERATIVE DISEASES; SIGNAL TRANSDUCTION;

EID: 79960533372     PISSN: 01999885     EISSN: 15454312     Source Type: Book Series    
DOI: 10.1146/annurev.nutr.012809.104635     Document Type: Article

References (216)

1. Agostoni C. 2008. Role of long-chain polyunsaturated fatty acids in the first year of life. J. Pediatr. Gastroenterol. Nutr. 47:S41-44
2. AkbarM,Calderon F, Wen Z,Kim H. 2005. Docosahexaenoic acid: a positivemodulator of Akt signaling in neuronal survival. Proc. Natl. Acad. Sci. USA 102:10858-63 (Pubitemid 41105957)
3. Amor S, Puentes F, Baker D, van der Valk P. 2010. Inflammation in neurodegenerative diseases. Immunology 129:154-69
4. Anders A, Gilbert S, Garten W, Postina R, Fahrenholz F. 2001. Regulation of the alpha-secretase ADAM10 by its prodomain and proprotein convertases. FASEB J. 15:1837-39
5. Anderson RE, Maude MB, McClellan M, Matthes MT, Yasumura D, LaVail MM. 2002. Low docosahexaenoic acid levels in rod outer segments of rats with P23H and S334ter rhodopsin mutations. Mol. Vis. 8:351-58 (Pubitemid 36153625)
6. Andreoli CM, Miller JW. 2007. Anti-vascular endothelial growth factor therapy for ocular neovascular disease. Curr. Opin. Ophthalmol. 18:502-8 (Pubitemid 351339405)
7. Antony R, Lukiw WJ, Bazan NG. 2010. Neuroprotectin D1 induces dephosphorylation of Bcl-xL in a PP2A-dependent manner during oxidative stress and promotes retinal pigment epithelial cell survival. J. Biol. Chem. 285:18301-8
8. Astarita G, Jung K, Berchtold NC, Nguyen VQ, Gillen DL, et al. 2010. Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease. PLoS ONE 5:e12538
9. Aveldãno MI. 1988. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry 27:1229-39 (Pubitemid 18063679)
10. Aveldãno MI, Bazan NG. 1972. High content of docosahexaenoate and of total diacylglycerol in retina. Biochem. Biophys. Res. Commun. 48:689-93
11. Aveldãno MI,BazanNG.1973. Fatty acid composition and level of diacylglycerols and phosphoglycerides in brain and retina. Biochim. Biophys. Acta 296:1-9
12. Aveldãno MI, Bazan NG. 1974. Displacement into incubation medium by albumin of highly unsaturated retina free fatty acids arising from membrane lipids. FEBS Lett. 40:53-56
13. Aveldãno MI, Bazan NG. 1975. Differential lipid deacylation during brain ischemia in a homeotherm and a poikilotherm. Content and composition of free fatty acids and triacylglycerols. Brain Res. 100:99-110
14. Aveldãno MI, Bazan NG. 1977. Acyl groups, molecular species and labeling by 14C-glycerol and 3Harachidonic acid of vertebrate retina glycerolipids. Adv. Exp. Med. Biol. 38:397-404
15. Aveldãno MI, Bazan NG. 1980. Composition and biosynthesis of molecular species of retina phosphoglycerides. Neurochem. Int. 1:381-92
16. Aveldãno MI, Giusto NM, Bazan NG. 1981 Polyunsaturated fatty acids of the retina. Prog. Lipid Res. 20:49-57
17. Aveldãno MI, Bazan NG. 1983. Molecular species of phosphatidylcholine,-ethanolamine,-serine, and-inositol in microsomal and photoreceptor membranes of bovine retina. J. Lipid Res. 24:620-27 (Pubitemid 13001067)
18. Aveldãno MI, Pasquare de Garcia SJ, Bazan NG. 1983. Biosynthesis of molecular species of inositol, choline, serine, and ethanolamine glycerophospholipids in the bovine retina. J. Lipid Res. 24:628-38 (Pubitemid 13059196)
19. Aveldãno MI. 1988. Phospholipid species containing long and very long polyenoic fatty acids remain with rhodopsin after hexane extraction of photoreceptor membranes. Biochemistry 27:1229-39 (Pubitemid 18063679)
20. Avramovich Y, Amit T, Youdim MB. 2002. Non-steroidal anti-inflammatory drugs stimulate secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 277:31466-73 (Pubitemid 34968947)
21. Bazan NG, Silvia di Fazio de Escalante M, Careaga MM, Bazan HE, GiustoNM. 1982. High content of 22:6 (docosahexaenoate) and active [2-3H]glycerol metabolism of phosphatidic acid from photoreceptor membranes. Biochim. Biophys. Acta 712:702-6
22. Bazan HE, Sprecher H, Bazan NG. 1984. De novo biosynthesis of docosahexaenoyl-phosphatidic acid in bovine retinal microsomes. Biochim. Biophys. Acta 796:11-19 (Pubitemid 15208394)
23. Bazan NG. 1990. Supply of n-3 polyunsaturated fatty acids and their significance in the central nervous system. In Nutrition and the Brain, vol. 8, ed. RJ Wurtman, JJ Wurtman, pp. 1-24. New York: Raven
24. Bazan NG. 2003. Synaptic lipid signaling: significance of polyunsaturated fatty acids and plateletactivating factor. J. Lipid Res. 44:2221-33 (Pubitemid 38082480)
25. Bazan NG. 2006. Cell survival matters: docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 29:263-71
26. Bazan NG. 2007. Homeostatic regulation of photoreceptor cell integrity: significance of the potent mediator neuroprotectin D1 biosynthesized from docosahexaenoic acid: the Proctor Lecture. Invest. Ophthalmol. Vis. Sci. 48:4866-81 (Pubitemid 351260891)
27. Bazan NG. 2009. Neuroprotectin D1-mediated anti-inflammatory and survival signaling in stroke, retinal degenerations, and Alzheimer's disease. J. Lipid Res. 50:S400-5
28. Bazan NG, BirkleDL, Reddy TS. 1984. Docosahexaenoic acid (22:6, n-3) is metabolized to lipoxygenase reaction products in the retina. Biochem. Biophys. Res. Commun. 125:741-47 (Pubitemid 15155759)
29. Bazan NG, Birkle DL, Reddy TS. 1985. Biochemical and nutritional aspects of the metabolism of polyunsaturated fatty acids and phospholipids in experimental models of retinal degeneration. In Retinal Degeneration: Experimental and Clinical Studies, ed.MMLaVail, JG Hollyfield, RE Anderson, pp. 159-87. New York: Liss
30. Bazan NG, Giusto NM. 1980. Docosahexaenoyl chains are introduced in phosphatic acid during de novo synthesis in retinal microsomes. In Control of Membrane Fluidity, ed.MKates, A Kukis, pp. 223-36. Totowa, NJ: Humana
31. Bazan NG, Gordon WC, Rodriguez de Turco EB. 1992. Docosahexaenoic acid uptake and metabolism in photoreceptors: retinal conservation by an efficient retinal pigment epithelial cell-mediated recycling process. Adv. Exp. Med. Biol. 318:295-306
32. Bazan NG, Reddy TS, Redmond TM, Wiggert B, Chader GJ. 1985. Endogenous fatty acids are covalently and noncovalently bound to interphotoreceptor retinoid-binding protein in the monkey retina. J. Biol. Chem. 260:13677-80 (Pubitemid 16233219)
33. Bazan NG, Rodriguez de Turco EB, Gordon WC. 1993. Pathways for the uptake and conservation of docosahexaenoic acid in photoreceptors and synapses: biochemical and autoradiographic studies. Can. J. Physiol. Pharmacol. 71:690-98 (Pubitemid 24025086)
34. Bazan NG, Scott BL. 1990. Dietary omega-3 fatty acids and accumulation of docosahexaenoic acid in rod photoreceptor cells of the retina and at synapses. Ups. J. Med. Sci. Suppl. 48:97-107 (Pubitemid 20371742)
35. Bazan NG, Scott BL, Reddy TS, Pelias MZ. 1986. Decreased content of docosahexaenoate and arachidonate in plasma phospholipids in Usher's syndrome. Biochem. Biophys. Res. Commun. 141:600-4 (Pubitemid 17001904)
36. Bernardo A, Minghetti L. 2006. PPAR-gamma agonists as regulators of microglial activation and brain inflammation. Curr. Pharm. Des. 12:93-109
37. Bertram L, Lill CM, Tanzi RE. 2010. The genetics of Alzheimer disease: back to the future. Neuron 68:270-81
38. Bettler J, Zimmer JP, Neuringer M, DeRusso PA. 2010. Serum lutein concentrations in healthy term infants fed human milk or infant formula with lutein. Eur. J. Nutr. 49:45-51
39. B́ezard J, Blond JP, Bernard A, Clouet P. 1994. The metabolism and availability of essential fatty acids in animal and human tissues. Reprod. Nutr. Dev. 34:539-68
40. Bibb C, Young RW. 1974. Renewal of fatty acids in the membranes of visual cell outer segments. J. Cell Biol. 61:327-43
41. Bird AC. 2003. The Bowman Lecture. Towards an understanding of age-related macular disease. Eye 17:457-66 (Pubitemid 36675758)
42. Bourre JM, Francois M, Youyou A, Dumont O, Piciotti M, et al. 1989. The effects of dietary alphalinolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119:1880-92 (Pubitemid 20063881)
43. BresslerNM.2009. Antiangiogenic approaches to age-related macular degeneration today. Ophthalmology 116:S15-23
44. Calandria JM,Marcheselli VL,Mukherjee PK,Uddin J,Winkler JW, et al. 2009. Selective survival rescue in 15-lipoxygenase-1-deficient retinal pigment epithelial cells by the novel docosahexaenoic acid-derived mediator, neuroprotectin D1. J. Biol. Chem. 284:17877-82
45. Camacho IE, Serneels L, Spittaels K, Merchiers P, Dominguez D, De Strooper B. 2004. Peroxisomeproliferator-activated receptor gamma induces a clearance mechanism for the amyloid-beta peptide. J. Neurosci. 24:10908-17 (Pubitemid 39602402)
46. Cansev M, Ulus IH, Wang L,Maher TJ,Wurtman RJ. 2008. Restorative effects of uridine plus docosahexaenoic acid in a rat model of Parkinson's disease. Neurosci. Res. 62:206-9
47. Chang GQ, Hao Y,Wong F. 1993. Apoptosis: final common pathway of photoreceptor death in rd, rds, and rhodopsin mutant mice. Neuron 11:595-605 (Pubitemid 23321770)
48. Chapus C, Rovery M, Sarda L, Verger R. 1988. Minireview on pancreatic lipase and colipase. Biochimie 70:1223-34 (Pubitemid 18259723)
49. Coletta JM, Bell SJ, Roman AS. 2010. Omega-3 fatty acids and pregnancy. Rev. Obstet. Gynecol. 3:163-71
50. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, et al. 2007. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat. Med. 13:868-73 (Pubitemid 47038185)
51. Crawford MA. 1990. The early development and evolution of the human brain. Ups. J. Med. Sci. Suppl. 48:43-78 (Pubitemid 20371740)
52. d'Abramo C, Massone S, Zingg JM, Pizzuti A, Marambaud P, et al. 2005. Role of peroxisome proliferatoractivated receptor gamma in amyloid precursor protein processing and amyloid beta-mediated cell death. Biochem. J. 391:693-98 (Pubitemid 41634796)
53. De Caterina R. 2001. n-3 Fatty acids and the inflammatory response-biological background. Eur. Heart J. Suppl. 3:D42-49 (Pubitemid 33713199)
54. de Jong PT. 2006. Age-related macular degeneration. N. Engl. J. Med. 355:1474-85 (Pubitemid 44511562)
55. DeMar JC Jr, Ma K, Bell JM, Igarashi M, Greenstein D, Rapoport SI. 2006. One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats. J. Lipid Res. 47:172-80 (Pubitemid 43107460)
56. de Urquiza AM, Liu S, Sj̈oberg M, Zetterstr ̈om RH, Griffiths W, et al. 2000. Docosahexaenoic acid, a ligand for the retinoid X receptor in mouse brain. Science 290:2140-44 (Pubitemid 32001593)
57. Drozdowski L, Thomson AB. 2006. Aging and the intestine. World J. Gastroenterol. 12:7578-84 (Pubitemid 46040567)
58. Dunaief JL, Dentchew T, Ying GS, Milam AH. 2002. The role of apoptosis in age-related macular degeneration. Arch. Ophthalmol. 120:1435-42 (Pubitemid 36406417)
59. Edwards AO, Ritter R 3rd, Abel KJ,Manning A, Panhuysen C, Farrer LA. 2005. Complement factor H polymorphism and age-related macular degeneration. Science 308:421-24 (Pubitemid 40530082)
60. Erie JC,McLaren JW,Hodge DO, Bourne WM. 2005. Recovery of corneal subbasal nerve density after PRK and LASIK. Am. J. Ophthalmol. 140:1059-64
61. Esquenazi S, Bazan HE, Bui V, He J, Kim DB, Bazan NG. 2005. Topical combination of NGF and DHA increases rabbit corneal nerve regeneration after photorefractive keratectomy. Invest. Ophthalmol. Vis. Sci. 46:3121-27 (Pubitemid 44264296)
62. Faghiri Z, Bazan NG. 2010. PI3K/Akt and mTOR/p70S6K pathways mediate neuroprotectin D1-induced retinal pigment epithelial cell survival during oxidative stress-induced apoptosis. Exp. Eye Res. 90:718-25
63. Feher J, Kovacs I, Artico M, Cavallotti C, Papale A, Balacco Gabrieli C. 2006. Mitochondrial alterations of retinal pigment epithelium in age-related macular degeneration. Neurobiol. Aging 27:983-93 (Pubitemid 44262273)
64. Feiz V, Mannis MJ, Kandavel G, McCarthy M, Izquierdo L, et al. 2001. Surface keratopathy after penetrating keratoplasty. Trans. Am. Ophthalmol. Soc. 99:159-68
65. Fliesler SJ, Anderson RE. 1983. Chemistry and metabolism of lipids in the vertebrate retina. Prog. Lipid Res. 22:79-131
66. Fotuhi M, Mohassel P, Yaffe K. 2009. Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association. Nat. Clin. Pract. Neurol. 5:140-52
67. Freund-Levi Y, Eriksdotter-J̈onhagen M, Cederholm T, Basun H, Fax́en-Irving G, et al. 2006. Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. Arch. Neurol. 63:1402-8 (Pubitemid 44547551)
68. Galasko D, Montine TJ. 2010. Biomarkers of oxidative damage and inflammation in Alzheimer's disease. Biomark. Med. 4:27-36
69. Gao F, Kiesewetter D, Chang L, Ma K, Bell JM, et al. 2009. Whole-body synthesis-secretion rates of long-chain n-3 PUFAs from circulating unesterified alpha-linolenic acid in unanesthetized rats. J. Lipid Res. 50:749-58
70. Garcia MC, Kim H. 1997. Mobilization of arachidonate and docosahexaenoate by stimulation of the 5-HT2A receptor in rat C6 glioma cells. Brain Res. 768:43-48 (Pubitemid 27433475)
71. Gerhardt H. 2008. VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4:241-46
72. Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, et al. 2007. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc. Natl. Acad. Sci. USA 104:18754-59 (Pubitemid 350210769)
73. Gil A. 2002. Polyunsaturated fatty acids and inflammatory diseases. Biomed. Pharmacother. 56:388-96 (Pubitemid 35232741)
74. Giovacchini G, Chang MC, Channing MA, Toczek M, Mason A, et al. 2002. Brain incorporation of [11C]arachidonic acid in young healthy humans measured with positron emission tomography. J. Cereb. Blood Flow Metab. 22:1453-62 (Pubitemid 35424930)
75. Goedert M, Clavaguera F, Tolnay M. 2010. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33:317-25
76. Gold B, Merriam JE, Zernant J, Hancox LS, Taiber AJ, et al. 2006. Variation in factor B (BF) and complement 2 (C2) genes is associated with age-related macular degeneration. Nat. Genet. 38:458-62
77. Golde TE, Dickson D, HuttonM. 2006. Filling the gaps in the abeta cascade hypothesis of Alzheimer's disease. Curr. Alzheimer Res. 3:421-30 (Pubitemid 46066421)
78. Gong J, Rosner B, Rees DG, Berson EL, Weigel-DiFranco CA, Schaefer EJ. 1992. Plasma docosahexaenoic acid levels in various genetic forms of retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 33:2596-602
79. Gonźalez-Ṕeriz A, Horrillo R, Ferŕe N, Gronert K, Dong B, et al. 2009. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. FASEB J. 23:1946-57
80. Gonźalez-Ṕeriz A, Planagum̀a A, Gronert K, Miquel R, Ĺopez-Parra M, et al. 2006. Docosahexaenoic acid (DHA) blunts liver injury by conversion to protective lipid mediators: protectinD1 and 17S-hydroxy-DHA. FASEB J. 20:2537-39
81. Gordon WC, Bazan NG. 1990. Docosahexaenoic acid utilization during rod photoreceptor cell renewal. J. Neurosci. 10:2190-202
82. Gordon WC, Rodriguez de Turco EB, Bazan NG. 1992. Retinal pigment epithelial cells play a central role in the conservation of docosahexaenoic acid by photoreceptor cells after shedding and phagocytosis. Curr. Eye Res. 11:73-83
83. Green KN, Martinez-Coria H, Khashwji H, Hall EB, Yurko-Mauro KA, et al. 2007. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-beta and tau pathology via a mechanism involving presenilin 1 levels. J. Neurosci. 27:4385-95 (Pubitemid 46640724)
84. Grisanti S, Tatar O. 2008. The role of vascular endothelial growth factor and other endogenous interplayers in age-related macular degeneration. Prog. Retin. Eye Res. 27:372-90
85. Haass C. 2010. Initiation and propagation of neurodegeneration. Nat. Med. 16:1201-4
86. Haass C, Mandelkow E. 2010. Fyn-tau-amyloid: a toxic triad. Cell 142:356-58
87. HaassC, Selkoe DJ. 2007. Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide. Nat. Rev. Mol. Cell Biol. 8:101-12 (Pubitemid 46432529)
88. Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, et al. 2005. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisphotoreceptor outer segment predisposes individuals to age-related macular degeneration. Proc. Natl. Acad. Sci. USA 102:7227-32 (Pubitemid 40696361)
89. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, et al. 2005. Complement factor H variant increases the risk of age-related macular degeneration. Science 308:419-21 (Pubitemid 40530081)
90. Hamilton J, Greiner R, Salem N, Kim H. 2000. N-3 Fatty acid deficiency decreases phosphatidylserine accumulation selectively in neuronal tissues. Lipids 35:863-69
91. Hassan IR, Gronert K. 2009. Acute changes in dietary omega-3 and omega-6 polyunsaturated fatty acids have a pronounced impact on survival following ischemic renal injury and formation of renoprotective docosahexaenoic acid-derived protectin D1. J. Immunol. 182:3223-32
92. Henke BR. 2004. Peroxisome proliferator-activated receptor gamma (PPARgamma) ligands and their therapeutic utility. Prog. Med. Chem. 42:1-53 (Pubitemid 39752464)
93. Hirsch D, Stahl A, Lodish HF. 1998. A family of fatty acid transporters conserved from mycobacterium to man. Proc. Natl. Acad. Sci. USA 95:8625-29 (Pubitemid 28350538)
94. HoffmanDR, Birch DG. 1995. Docosahexaenoic acid in red blood cells of patients with X-linked retinitis pigmentosa. Invest. Ophthalmol. Vis. Sci. 36:1009-18
95. Hoffman DR, Boettcher JA, Diersen-Schade DA. 2009. Toward optimizing vision and cognition in term infants by dietary docosahexaenoic and arachidonic acid supplementation: a review of randomized controlled trials. Prostaglandins Leukot. Essent. Fatty Acids. 81:151-58
96. Hoffman DR, DeMar JC, Heird WC, Birch DG, Anderson RE. 2001. Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J. Lipid Res. 42:1395-401 (Pubitemid 34007669)
97. Hoffman DR, Uauy R, Birch DG. 1993. Red blood cell fatty acid levels in patients with autosomal dominant retinitis pigmentosa. Exp. Eye Res. 57:359-68 (Pubitemid 23288815)
98. Holman RT. 1986. Control of polyunsaturated acids in tissue lipids. J. Am. Coll. Nutr. 5:183-211 (Pubitemid 16083228)
99. Horrocks LA, Farooqui AA. 1994. NMDA receptor-stimulated release of arachidonic acid: mechanisms for the Bazan effect. In Cell Signal Transduction, Second Messengers, and Protein Phosphorylation in Health and Disease, ed. AM Municio, MT Miras-Portugal, pp. 113-28. New York: Plenum
100. Hu J, Bok D. 2001. A cell culture medium that supports the differentiation of human retinal pigment epithelium into functionally polarized monolayers. Mol. Vis. 7:14-19 (Pubitemid 36153646)
101. Huss M, Volp A, Stauss-GraboM. 2010. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems-an observational cohort study. Lipids Health Dis. 9:105
102. Itoh T, Fairall L, AminK, Inaba Y, Szanto A, et al. 2008. Structural basis for the activation ofPPARgamma by oxidized fatty acids. Nat. Struct. Mol. Biol. 15:924-31
103. Jang JH, Surh YJ. 2005. Beta-amyloid-induced apoptosis is associated with cyclooxygenase-2 upregulation via the mitogen-activated protein kinase-NF-kappaB signaling pathway. Free Radic. Biol.Med. 38:1604-13
104. Jeffrey BG, NeuringerM. 2009. Age-related decline in rod phototransduction sensitivity in rhesus monkeys fed an n-3 fatty acid-deficient diet. Invest. Ophthalmol. Vis. Sci. 50:4360-67
105. Jump DB, Botolin D, Wang Y, Xu J, Christian B, Demeure O. 2005. Fatty acid regulation of hepatic gene transcription. J. Nutr. 135:2503-6 (Pubitemid 43156586)
106. Jump DB, Botolin D, Wang Y, Xu J, Demeure O, Christian B. 2008. Docosahexaenoic acid (DHA) and hepatic gene transcription. Chem. Phys. Lipids. 153:3-13
107. Jump DB, Thelen A, Ren B, Mater M. 1999. Multiple mechanisms for polyunsaturated fatty acid regulation of hepatic gene transcription. Prostaglandins Leukot. Essent. Fatty Acids 60:345-49 (Pubitemid 29401790)
108. Kalant D, Cianflone K. 2004. Regulation of fatty acid transport. Curr. Opin. Lipidol. 15:309-14 (Pubitemid 38716564)
109. Kanda A, Abecasis G, Swaroop A. 2008. Inflammation in the pathogenesis of age-related macular degeneration. Br. J. Ophthalmol. 92:448-50 (Pubitemid 351497965)
110. KaushikM,Mozaffarian D, Spiegelman D, Manson JE, Willett WC,Hu FB. 2009. Long-chain omega-3 fatty acids, fish intake, and the risk of type 2 diabetes mellitus. Am. J. Clin. Nutr. 90:613-20
111. Kerkar S, Williams M, Blocksom JM, Wilson RF, Tyburski JG, Steffes CP. 2006. TNF-alpha and IL-1beta increase pericyte/endothelial cell co-culture permeability. J. Surg. Res. 132:40-45
112. Kim H. 2007. Novel metabolism of docosahexaenoic acid in neural cells. J. Biol. Chem. 282:18661-65 (Pubitemid 47100128)
113. Kim HY, Akbar M, Kim KY. 2001. Inhibition of neuronal apoptosis by polyunsaturated fatty acids. J. Mol. Neurosci. 16:223-27 (Pubitemid 32664783)
114. Kim H, Akbar M, Kim Y. 2010. Phosphatidylserine-dependent neuroprotective signaling promoted by docosahexaenoic acid. Prostaglandins Leukot. Essent. Fatty Acids 82:165-72
115. KimH, Akbar M, Lau A. 2003. Effects of docosapentaenoic acid on neuronal apoptosis. Lipids 38:453-57 (Pubitemid 36724305)
116. Kim HY, Akbar M, Lau A, Edsall L. 2000. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J. Biol. Chem. 275:35215-23
117. Kim HY, Edsall L, Garcia M, Zhang H. 1999. The release of polyunsaturated fatty acids and their lipoxygenation in the brain. Adv. Exp. Med. Biol. 447:75-85 (Pubitemid 32448222)
118. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, et al. 2005. Complement factor H polymorphism in age-related macular degeneration. Science 308:385-89 (Pubitemid 40530070)
119. Laýe S. 2010. Polyunsaturated fatty acids, neuroinflammation and well being. Prostaglandins Leukot. Essent. Fatty Acids 82:295-303
120. Lee BH, McLaren JW, Erie JC, Hodge DO, Bourne WM. 2002. Reinnervation in the cornea after LASIK. Invest. Ophthalmol. Vis. Sci. 43:3660-64 (Pubitemid 35470601)
121. Lee SA, Kim HJ, Chang KC, Baek JC, Park JK, et al. 2009. DHA and EPA down-regulate COX-2 expression through suppression of NF-kappaB activity in LPS treated human umbilical vein endothelial cells. Korean J. Physiol. Pharmacol. 13:301-7
122. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Snodderly DM. 2004. Nutritional manipulation of primate retinas, II: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. 45:3244-56 (Pubitemid 39121862)
123. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Snodderly DM. 2005. Nutritional manipulation of primate retinas. IV. Effects of n-3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region. Exp. Eye Res. 81:513-29 (Pubitemid 41531997)
124. Li F, Cao W, Anderson RE. 2001. Protection of photoreceptor cells in adult rats from light-induced degeneration by adaptation to bright cyclic light. Exp. Eye Res. 73:569-77 (Pubitemid 33078231)
125. Lim GP, Calon F, Morihara T, Yang F, Teter B, et al. 2005. A diet enriched with the omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J. Neurosci. 25:3032-40 (Pubitemid 40463537)
126. Lim SY, Hoshiba J, Moriguchi T, Salem N Jr. 2005. N-3 fatty acid deficiency induced by a modified artificial rearing method leads to poorer performance in spatial learning tasks. Pediatr. Res. 58:741-48 (Pubitemid 41368907)
127. Lim SY, Hoshiba J, SalemNJr. 2005.Anextraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance. J. Neurochem. 95:848-57 (Pubitemid 41567175)
128. Long EK, Murphy TC, Leiphon LJ, Watt J, Morrow JD, et al. 2008. Trans-4-hydroxy-2-hexenal is a neurotoxic product of docosahexaenoic (22:6; n-3) acid oxidation. J. Neurochem. 105:714-24 (Pubitemid 351562721)
129. Lukiw WJ, Cui J, Marcheselli VL, Bodker M, Botkjaer A, et al. 2005. A role for docosahexaenoic acidderived neuroprotectin D1 in neural cell survival and Alzheimer disease. J. Clin. Invest. 115:2774-83 (Pubitemid 41434404)
130. Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finley J, et al. 2003. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF expression in retinal cells by hypoxia. Invest. Ophthalmol. Vis. Sci. 44:4163-70 (Pubitemid 37186247)
131. Ma QL, Teter B, Ubeda OJ, Morihara T, Dhoot D, et al. 2007. Omega-3 fatty acid docosahexaenoic acid increases SorLA/LR11, a sorting protein with reduced expression in sporadic Alzheimer's disease (AD): relevance to AD prevention. J. Neurosci. 27:14299-307
132. Marcheselli VL, Hong S, Lukiw WJ, Tian XH, Gronert K, et al. 2003. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J. Biol. Chem. 278:43807-17 (Pubitemid 37346009)
133. Marcheselli VL, Mukherjee PK, Arita M, Hong S, Antony R, et al. 2010. Neuroprotectin D1/protectin D1 stereoselective and specific binding with human retinal pigment epithelial cells and neutrophils. Prostaglandins Leukot. Essent. Fatty Acids 82:27-34
134. Marion-Letellier R, Butler M, Dechelotte P, Playford RJ, Ghosh S. 2008. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells. Am. J. Clin. Nutr. 87:939-48
135. Masson CJ, Plat J, Mensink RP, Namiot A, Kisielewski W, et al. 2010. Fatty acid and cholesterol transporter protein expression along the human intestinal tract. PLoS ONE 5:e10380
136. Maude MB, Anderson EO, Anderson RE. 1998. Polyunsaturated fatty acids are lower in blood lipids of Usher's type I but not Usher's type II. Invest. Ophthalmol. Vis. Sci. 39:2164-66 (Pubitemid 28455087)
137. McNamara RK, Jandacek R, Rider T, Tso P, Cole-Strauss A, Lipton JW. 2010. Omega-3 fatty acid deficiency increases constitutive pro-inflammatory cytokine production in rats: relationship with central serotonin turnover. Prostaglandins Leukot. Essent. Fatty Acids 83:185-91
138. Mendes HF, van der Spuy J, Chapple JP, Cheetham ME. 2005. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 11:177-85
139. McColl AJ, Converse CA. 1995. Lipid studies in retinitis pigmentosa. Prog. Lipid Res. 349:1-16
140. Moore SA. 2001. Polyunsaturated fatty acid synthesis and release by brain-derived cells in vitro. J. Mol. Neurosci. 16:195-200 (Pubitemid 32664779)
141. Moore SA, Yoder E, Murphy S, Dutton GR, Spector AA. 1991. Astrocytes, not neurons, produce docosahexaenoic acid (22:6 omega-3) and arachidonic acid (20:4 omega-6). J. Neurochem. 56:518-24 (Pubitemid 21901992)
142. Moriguchi T, Lim S, Greiner R, LefkowitzW, Loewke J, et al. 2004. Effects of an n-3-deficient diet on brain, retina, and liver fatty acyl composition in artificially reared rats. J. Lipid Res. 45:1437-45 (Pubitemid 39006971)
143. Mukherjee PK, Marcheselli VL, Barreiro S, Hu J, Bok D, Bazan NG. 2007b. Neurotrophins enhance retinal pigment epithelial cell survival through neuroprotectin D1 signaling. Proc. Natl. Acad. Sci. USA 104:13152-57 (Pubitemid 351737608)
144. Mukherjee PK, Marcheselli VL, deRivero Vaccari JC, GordonWC,Jackson FE, Bazan NG. 2007a. Photoreceptor outer segment phagocytosis attenuates oxidative stress-induced apoptosis with concomitant neuroprotectin D1 synthesis. Proc. Natl. Acad. Sci. USA 104:13158-63 (Pubitemid 351737609)
145. Mukherjee PK, Marcheselli VL, Serhan CN, Bazan NG. 2004. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc. Natl. Acad. Sci. USA 101:8491-96 (Pubitemid 38736602)
146. Muller LJ, Marfurt CF, Kruse F, Tervo TM. 2003. Corneal nerves: structure, contents and function. Exp. Eye Res. 76:521-42 (Pubitemid 36411929)
147. Musiek ES, Brooks JD, Joo M, Brunoldi E, Porta A, et al. 2008. Electrophilic cyclopentenone neuroprostanes are anti-inflammatory mediators formed from the peroxidation of the omega-3 polyunsaturated fatty acid docosahexaenoic acid. J. Biol. Chem. 283:19927-35
148. NeelyMD, Zimmerman L, Picklo MJ, Ou JJ, Morales CR, et al. 2000. Congeners ofN(alpha)-acetyl-Lcysteine but not aminoguanidine act as neuroprotectants from the lipid peroxidation product 4-hydroxy-2-nonenal. Free Radic. Biol. Med. 29:1028-36
149. Nicklas WJ, Vyas I, Heikkila RE. 1985. Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine. Life Sci. 36:2503-8 (Pubitemid 15072756)
150. Novak EM, Dyer RA, Innis SM. 2008. High dietary [omega]-6 fatty acids contribute to reduced docosahexaenoic acid in the developing brain and inhibit secondary neurite growth. Brain Res. 237:136-45
151. OksmanM, Iivonen H, Hogyes E, Amtul Z, Penke B, et al. 2006. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice. Neurobiol. Dis. 23:563-72 (Pubitemid 44234092)
152. Organisciak DT,Darrow RM, Jiang YL, Blanks JC. 1996. Retinal light damage in rats with altered levels of rod outer segment docosahexaenoate. Invest. Ophthalmol. Vis. Sci. 37:2243-57 (Pubitemid 26338773)
153. Ou J, Tu H, Shan B, Luk A, DeBose-Boyd RA, et al. 2001. Unsaturated fatty acids inhibit transcription of the sterol regulatory element-binding protein-1c (SREBP-1c) gene by antagonizing ligand-dependent activation of the LXR. Proc. Natl. Acad. Sci. USA 98:6027-32 (Pubitemid 32488187)
154. Palacios-Pelaez R, Lukiw WJ, Bazan NG. 2010. Omega-3 essential fatty acids modulate initiation and progression of neurodegenerative disease. Mol. Neurobiol. 41:367-74
155. Papermaster DS. 2002. The birth and death of photoreceptors: the Friedenwald Lecture. Invest. Ophthalmol. Vis. Sci. 43:1300-9 (Pubitemid 34462623)
156. Patel SV, Erie JC,McLaren JW, Bourne WM. 2007. Keratocyte density and recovery of subbasal nerves after penetrating keratoplasty and late endothelial failure. Arch. Ophthalmol. 125:1693-98 (Pubitemid 350254886)
157. Patel SV, McLaren JW, Hodge DO, Bourne WM. 2002. Confocal microscopy in vivo in corneas of long-term contact lens wearers. Invest. Ophthalmol. Vis. Sci. 43:995-1003 (Pubitemid 34258266)
158. Peng Y, Lee DY, Jiang L, Ma Z, Schachter SC, Lemere CA. 2007. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695. Neuroscience 150:386-95 (Pubitemid 350199698)
159. Petursdottir AL, Farr SA, Morley JE, Banks WA, Skuladottir GV. 2008. Effect of dietary n-3 polyunsaturated fatty acids on brain lipid fatty acid composition, learning ability, and memory of senescenceaccelerated mouse. J. Gerontol. A Biol. Sci. Med. Sci. 63:1153-60 (Pubitemid 352772035)
160. Politi LE, Rotstein NP,Carri NG. 2001. Effect ofGDNFon neuroblast proliferation and photoreceptor survival: additive protection with docosahexaenoic acid. Invest. Ophthalmol. Vis. Sci. 42:3008-15 (Pubitemid 33035303)
161. Portera-Cailliau C, Sung CH, Nathans J, Adler R. 1994. Apoptotic photoreceptor cell death in mouse models of retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 91:974-78 (Pubitemid 24048491)
162. Qin Q, Patil KA, Gronert K, Sharma SC. 2008. Neuroprotectin D1 inhibits retinal ganglion cell death following axotomy. Prostaglandins Leukot. Essent. Fatty Acids 79:201-7
163. Quinn JF, Raman R, Thomas RG, Yurko-Mauro K, Nelson EB, et al. 2010. Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. JAMA 304:1903-11
164. Rapoport SI, Igarashi M. 2009. Can the rat liver maintain normal brain DHA metabolism in the absence of dietary DHA? Prostaglandins Leukot. Essent. Fatty Acids 81:119-23
165. Rapoport SI, Igarashi M, Gao F. 2010. Quantitative contributions of diet and liver synthesis to docosahexaenoic acid homeostasis. Prostaglandins Leukot. Essent. Fatty Acids 82:273-76
166. Rapoport SI, Rao JS, Igarashi M. 2007. Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. Prostaglandins Leukot. Essent. Fatty Acids 77:251-61 (Pubitemid 350214520)
167. Rattner A, Nathans J. 2006. Macular degeneration: recent advances and therapeutic opportunities. Nat. Rev. Neurosci. 7:860-72 (Pubitemid 44624178)
168. Reddy TS, Bazan NG. 1984a. Activation of polyunsaturated fatty acids by rat tissues in vitro. Lipids 19:987-89 (Pubitemid 15196505)
169. Reddy TS, Bazan NG. 1984b. Synthesis of arachidonoyl coenzyme A and docosahexaenoyl coenzyme A in retina. Curr. Eye Res. 3:1225-32 (Pubitemid 14012205)
170. Reddy TS, Bazan NG. 1985a. Synthesis of arachidonoyl coenzyme A and docosahexaenoyl coenzyme A in synaptic plasma membranes of cerebrum and microsomes of cerebrum, cerebellum, and brain stem of rat brain. J. Neurosci. Res. 13:381-90 (Pubitemid 15107115)
171. Reddy TS, Bazan NG. 1985b. Synthesis of docosahexaenoyl-, arachidonoyl-and palmitoyl-coenzyme A in ocular tissues. Exp. Eye Res. 41:87-95 (Pubitemid 16165695)
172. Roberts LJ, Fessel JP, Davies SS. 2005. The biochemistry of the isoprostane, neuroprostane, and isofuran pathways of lipid peroxidation. Brain Pathol. 15:143-48 (Pubitemid 40546170)
173. RosenbergME, TervoTM,Immonen IJ, MullerLJ, Gronhagen-RiskaC,VesaluomaMH. 2000. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest. Ophthalmol. Vis. Sci. 41:2915-21
174. Rossner S, Sastre M, Bourne K, Lichtenthaler SF. 2006. Transcriptional and translational regulation of BACE1 expression-implications for Alzheimer's disease. Prog. Neurobiol. 79:95-111 (Pubitemid 44247281)
175. Sahlin C, Pettersson FE, Nilsson LN, Lannfelt L, Johansson AS. 2007. Docosahexaenoic acid stimulates non-amyloidogenic APP processing resulting in reduced Abeta levels in cellular models of Alzheimer's disease. Eur. J. Neurosci. 26:882-89 (Pubitemid 47274614)
176. Salem N, Litman B, Kim HY, Gawrisch K. 2001. Mechanisms of action of docosahexaenoic acid in the nervous system. Lipids 36:945-59 (Pubitemid 33065196)
177. Sall K, Stevenson OD, Mundorf TK, Reis BL. 2000. Twomulticenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology 107:631-39 (Pubitemid 30191329)
178. Samadi P, Gŕegoire L, Rouillard C, B́edard PJ, Di Paolo T, Ĺevesque D. 2006. Docosahexaenoic acid reduces levodopa-induced dyskinesias in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine monkeys. Biochemistry 45:15610-16
179. SanGiovanni JP, Chew EY. 2005. The role of omega-3 long-chain polyunsaturated fatty acids in health and disease of the retina. Prog. Retin. Eye Res. 24:87-138 (Pubitemid 39535157)
180. Sastre M, Dewachter I, Rossner S, Bogdanovic N, Rosen E, et al. 2006. Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc. Natl. Acad. Sci. USA 103:443-48 (Pubitemid 43122420)
181. Schaefer EJ, Robins SJ, Patton GM, Sandberg MA, Weigel-DiFranco CA, et al. 1995. Red blood cell membrane phosphatidylethanolamine fatty acid content in various forms of retinitis pigmentosa. J. Lipid Res. 36:1427-33
182. Schwab JM, ChiangN, Arita M, Serhan CN. 2007. Resolvin E1 and protectin D1 activate inflammationresolution programmes. Nature 447:869-74 (Pubitemid 46920139)
183. Scott BL, Bazan NG. 1989. Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. Proc. Natl. Acad. Sci. USA 86:2903-7 (Pubitemid 19112648)
184. Serhan CN. 2007. Resolution phase of inflammation: novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25:101-37 (Pubitemid 46697904)
185. Serhan CN, Gotlinger K, Hong S, Lu Y, Siegelman J, et al. 2006. Anti-inflammatory actions of neuroprotectin D1/protectin D1 and its natural stereoisomers: assignments of dihydroxy-containing docosatrienes. J. Immunol. 176:1848-59 (Pubitemid 43134330)
186. Serhan CN, Hong S, Gronert K, Colgan SP, Devchand PR, et al. 2002. Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals. J. Exp. Med. 196:1025-37 (Pubitemid 35231761)
187. Shen JK Dong A, Hackett SF, Bell WR, Green WR, Campochiaro PA. 2007. Oxidative damage in age-related macular degeneration. Histol. Histopathol. 22:1301-8 (Pubitemid 47470323)
188. Simonelli F, Manna C, Romano N, Nunziata G, Voto O, Rinaldi E. 1996. Evaluation of fatty acids in membrane phospholipids of erythrocytes in retinitis pigmentosa patients. Ophthalmic Res. 28:93-98 (Pubitemid 26164325)
189. Simopoulos AP. 1989. Summary of the NATO advanced research workshop on dietary omega 3 and omega 6 fatty acids: biological effects and nutritional essentiality. J. Nutr. 119:521-28
190. Simopoulos AP. 2001. n-3 fatty acids and human health: defining strategies for public policy. Lipids 36:S83-89 (Pubitemid 34106214)
191. Simopoulos AP. 2002a. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed. Pharmacother. 56:365-79 (Pubitemid 35232740)
192. Simopoulos AP. 2002b. Omega-3 fatty acids in inflammation and autoimmune diseases. J. Am. Coll. Nutr. 21:495-505 (Pubitemid 36026261)
193. Simopoulos AP. 2006. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed. Pharmacother. 60:502-7 (Pubitemid 44635081)
194. Simopoulos AP. 2008. The importance of the omega-6/omega-3 fatty acid ratio in cardiovascular disease and other chronic diseases. Exp. Biol. Med. 233:674-88
195. Singer P, Berger I, L̈uck K, Taube C, Naumann E, G̈odicke W. 1986. Long-term effect of mackerel diet on blood pressure, serum lipids and thromboxane formation in patients with mild essential hypertension. Atherosclerosis 62:259-65 (Pubitemid 17208645)
196. Singer P, Jaeger W, Voigt S, Thiel H. 1984. Defective desaturation and elongation of N-6 andN-3 fatty acids in hypertensive patients. Prostaglandins Leukot. Med. 15:159-65 (Pubitemid 14054976)
197. Singh M. 2005. Essential fatty acids, DHA and human brain. Indian J. Pediatr. 72:239-42 (Pubitemid 40529527)
198. Spencer KL, Hauser MA, Olson LM, Schmidt S, ScottWK, et al. 2007. Protective effect of complement factor B and complement component 2 variants in age-related macular degeneration. Hum. Mol. Genet. 16:1986-92 (Pubitemid 47354881)
199. Sreekumar PG, Kannan R, Yaung J, Spee CK, Ryan SJ, Hinton DR. 2005. Protection from oxidative stress by methionine sulfoxide reductases in RPE cells. Biochem. Biophys. Res. Commun. 334:245-53 (Pubitemid 40978532)
200. Stahl A, Gimeno RE, Tartaglia LA, Lodish HF. 2001. Fatty acid transport proteins: a current view of a growing family. Trends Endocrinol. Metab. 12:266-73 (Pubitemid 33714217)
201. Stahl A, Hirsch DJ, Gimeno RE, Punreddy S, Ge P, et al. 1999. Identification of the major intestinal fatty acid transport protein. Mol. Cell. 4:299-308 (Pubitemid 29499783)
202. Sun GY, Xu J, JensenMD,Simonyi A. 2004. PhospholipaseA2 in the central nervous system: implications for neurodegenerative diseases. J. Lipid Res. 45:205-13 (Pubitemid 38228817)
203. Szymczak M, Murray M, Petrovic N. 2008. Modulation of angiogenesis by ω-3 polyunsaturated fatty acids is mediated by cyclooxygenases. Blood 111:3514-21
204. Tanihara H, Inatani M, Honda Y. 1997. Growth factors and their receptors in the retina and pigment epithelium. Prog. Retin. Eye Res. 16:271-301 (Pubitemid 27060194)
205. Tanriover G, Seval-Celik Y, Ozsoy O, Akkoyunlu G, Savcioglu F, et al. 2010. The effects of docosahexaenoic acid on glial derived neurotrophic factor and neurturin in bilateral rat model of Parkinson's disease. Folia. Histochem. Cytobiol. 48:434-41
206. Tu B, Bazan NG. 2003. Hippocampal kindling epileptogenesis upregulates neuronal cyclooxygenase-2 expression in neocortex. Exp. Neurol. 179:167-75 (Pubitemid 36279616)
207. Vijitruth R, Liu M, Choi DY, Nguyen XV, Hunter RL, Bing G. 2006. Cyclooxygenase-2 mediates microglial activation and secondary dopaminergic cell death in the mouse MPTP model of Parkinson's disease. J. Neuroinflammation 3:6
208. Walsh DM, Selkoe DJ. 2007. A beta oligomers - a decade of discovery. J. Neurochem. 101:1172-84
209. Wisely GB,Miller AB, Davis RG, Thornquest AD Jr, Johnson R, et al. 2002. Hepatocyte nuclear factor 4 is a transcription factor that constitutively binds fatty acids. Structure 10:1225-34 (Pubitemid 35254011)
210. Yaffe K. 2010. Treatment of Alzheimer disease and prognosis of dementia: time to translate research to results. JAMA 304:1952-53
211. Yamamoto K, Itoh T, Abe D, Shimizu M, Kanda T, et al. 2005. Identification of putative metabolites of docosahexaenoic acid as potent PPARgamma agonists and antidiabetic agents. Bioorg. Med. Chem. Lett. 15:517-22
212. Yang HQ, Pan J, BaMW,Sun ZK,MaGZ, et al. 2007. New protein kinaseCactivator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity. Eur. J. Neurosci. 26:381-91 (Pubitemid 47087599)
213. Yurko-Mauro K, McCarthy D, Rom D, Nelson EB, Ryan AS, et al. 2010. Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimers Dement. 6:456-64
214. Zhao Y, Calon F, Julien C, Winkler JW, Petasis NA, et al. 2010. Docosahexaenoic acid-derived neuroprotectin D1 induces neuronal survival via secretase-and PPARγ-mediated mechanisms in Alzheimer's disease models. PLoS ONE 6:e15816
215. Zhao Y, Cui JG, Lukiw WJ. 2007. Reduction of sortilin-1 in Alzheimer hippocampus and in cytokinestressed human brain cells. Neuroreport 18:1187-91 (Pubitemid 46988077)
216. Zhao Y, Patzer A, Herdegen T, Gohlke P, Culman J. 2006. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J. 20:1162-75 (Pubitemid 44943912)